healthcare
healthcare Articles
Telemedicine platform provider GoodRx entered the market with a bang on Wednesday.
Published:
AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.
Published:
MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.
Published:
Illumina shares dipped early Monday after the company announced that it would be making a critical acquisition of Grail.
Published:
Precision oncology company PMV Pharmaceuticals intends to price more than 7.35 million shares for an initial public offering valued up to around $152 million.
Published:
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and back, which...
Published:
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Published:
Sorrento Therapeutics shares jumped on Thursday after the company announced that it received approval from the FDA for its COVID-19 treatment.
Published:
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday.
Published:
Last Updated:
The announcement of positive topline results in a late-stage epilepsy trial prompted a rally in Marinus Pharmaceuticals shares on Tuesday.
Published:
Companies winning approval from the FDA or beating a trial are expected in some cases. If investors already have priced this news into the stock, when it actually comes around they tend to sell the...
Published:
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
Published:
Cassava Sciences reported good results from a mid-stage study of its sumifilam treatment for Alzheimer's disease. Shares soared on the news.
Published:
Telemedicine platform provider GoodRx intends to price more than 34 million shares for an initial public offering valued up to more than $1 billion.
Published:
Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in one of the biggest deals to go down in the health care sector this year.
Published: